Navigation Links
Clinical Trial Strategies to Ensure Pharmaceutical Success in a Global Marketplace
Date:11/16/2012

CHAPEL HILL, N.C., Nov. 16, 2012 /PRNewswire/ -- Pharmaceutical organizations are experiencing two dynamics in mature markets like North America and Europe: Clinical costs are continuing to rise and sales are either rising negligibly or not at all.

In emerging markets, meanwhile, the pharma sector is experiencing lower clinical costs and rapidly rising sales. While mature markets still represent a lion's share of most companies' sales, emerging markets represent significant cost savings and important future sales. And large countries like China and India are now requiring local clinical trials to win regulatory approvals to market products in those countries.

What this all adds up to is pharma organizations need to continue expansion of their clinical programs into emerging markets to cut costs and boost sales.

A study from Best Practices, LLC, Clinical Affairs Excellence: Benchmarking Clinical Roles and Trends for Pharmaceutical Success in a Global Marketplace, presents difficult to find metrics associated with outsourcing clinical trial activities – including cost, staffing, and quality. Best Practices®, LLC conducted this study to inform clinical affairs leaders at pharmaceutical companies on benchmarks around vendor selection, outsourcing attributes, desired competencies and outsourcing levels for key clinical functions, clinical affairs structure and outsourcing trends. In addition, the study presents qualitative insights from participants around outsourcing success factors and pitfalls.

Research participants included seven executives and managers from six pharma companies across a wide variety of therapeutic areas and product classes. In addition, four executive interviews were conducted to collect qualitative insights.

Specifically the study encompasses the following key topic areas: 

  • Vendor Sele
    '/>"/>

SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
2. Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
3. Alliqua Appoints Dr. Joseph Laudano as Vice President of Medical Affairs to Support the Market Expansion of Alliquas SilverSeal Products and Future Clinical Development
4. Ampio Provides Progress Report on Clinical Programs in Preparation for Annual Shareholders Meeting
5. AspenBio Pharma Begins Training Hospital Sites for Pivotal Clinical Trial
6. PRA Named Clinical Company of the Year in National Contest
7. Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
8. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
9. 3-V Biosciences Presents Positive Preclinical Data on HCV Product Candidates Targeting FASN at the American Association for the Study of Liver Disease Annual Meeting 2012
10. Verum.de CEO to Present on International Clinical Trial Regulations at BIOCOM Event
11. Cannabis Science Provides Corporate Guidance on Preclinical Initiatives and Recent Corporate Developments for its Shareholders; CBIS Announces plans for 1st Q of 2013 Webinar Investor Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ( ... FDA, Health Canada and CE ( Europe ... Glasgow Science Centre in Scotland , ... the SynCardia temporary Total Artificial Heart powered ... $3 million Bodyworks Exhibition, one of the most advanced ...
(Date:5/23/2013)... , May 23, 2013  Echo Pharma Acquisition Limited ... waive down the Acceptance Threshold from 90 percent to ... Elan Share in accordance with the terms of the ... summarized below. Under the terms of the ... (NYSE: ELN ) for $12.50 per share ...
(Date:5/23/2013)... PARIS , May 23, 2013 ... (NYSE MKT: NSPR), the leader in embolic protection ... MASTER (MGuard for Acute ST Elevation Reperfusion) trial ... outperformed bare metal and drug eluting stents in ... (STEMI) patients.  Results from the trial were presented ...
Breaking Medicine Technology:Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
(Date:5/23/2013)... Dr. Garber's Natural Solutions is ... now available at Whole Foods Laguna Niguel, 23932 Aliso ... of natural biotherapy formulas continues to expand its' presence ... Brandstorm HBC (Los Angeles, CA), the line of remedies ... and Arizona, as well as Lassen's Markets in California, ...
(Date:5/23/2013)... May 23, 2013 On May 23, Voices ... and advocacy, commends Salem High School senior Max Merget for ... , According to a Patch.com article, Max Merget ... anaplastic ependymoma -- a large malignant tumor in the dominant, ... underwent surgery but the tumor came back a year later ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Brad Schmett, ... announced that the already sizzling Palm Springs area ... thanks to the immense popularity of the Annual Memorial ... on Monday, May 27, 2013. , Culminating the festive ... of programs and events along with flight exhibitions. However, ...
(Date:5/23/2013)... May 23, 2013 After working continuously ... beta testing regimes, Shopping Cart Elite officially ... Redsandmotorsports.com is an Arizona based online store retailing in ... , “Addition of new stores to our clientele has ... Cart Elite, Igor Soshkin. “We are extremely elated with ...
(Date:5/23/2013)... Texas (PRWEB) May 23, 2013 ... their daily routines, Walkingspree is pleased to announce ... with Fitbit pedometer devices. This new upgrade automatically ... dashboard members use to track their company’s team ... chart calories and fat burned. , Walkingspree also ...
Breaking Medicine News(10 mins):Health News:Dr. Garber's Natural Solutions Now Available at Whole Foods Market, Laguna Niguel, CA 2Health News:Voices Against Brain Cancer Commends Young Man for Raising Money for Brain Cancer Despite Fighting His Own Battle 2Health News:Annual Memorial Day Flower Drop Honors Veterans in Palm Springs California by Brad Schmett 2Health News:Shopping Cart Software Provider, Shopping Cart Elite Officially Announces the Launch Of Redsandmotorsports.com 2Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 2Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 3
... Va., Sept. 30 Military Officers Association ... Jr., USN (Ret), pulled no punches in expressing MOAA,s ... raising hospital inpatient copays by $110 per day for retired ... "We,re shocked and extremely disappointed that there would be any ...
... Anchor Bay Entertainment, the successful distributor of independent ... with Susan G. Komen for the Cure(®) in the ... months, Anchor Bay Entertainment will donate $1 for each ... well as develop specialized promotions for the campaign to ...
... ... AllerQuest, LLC, are pleased to announce the return of PRE-PEN® penicillin allergy skin testing ... has entered into a definitive agreement with AllerQuest to market and distribute PRE-PEN®. ... Round Rock, TX ...
... benefit when therapy goes to more than just severe ... -- Pregnant women who receive treatment for the mildest ... intervention, self-monitoring of blood glucose levels and possibly insulin ... complications or develop preeclampsia or high blood pressure during ...
... ... Investor and New England Patriots President Jonathan Kraft , ... Boston, MA (Vocus) September 30, 2009 -- The Boston biotechnology industry ... Boston Biotech R&D Conference on October 27, 2009 at Harvard Medical School. , , ...
... Sept. 30 Most American children don,t see their family ... later than is recommended by both dental and medical professionals. ... of American children,s oral health, conducted on behalf of Delta ... Dental commissioned the survey to gain greater knowledge about the ...
Cached Medicine News:Health News:MOAA Decries 21% TRICARE Inpatient Copay Hike 2Health News:Anchor Bay Entertainment Joins Forces With Susan G. Komen for the Cure(R) in the Fight Against Breast Cancer 2Health News:Anchor Bay Entertainment Joins Forces With Susan G. Komen for the Cure(R) in the Fight Against Breast Cancer 3Health News:FDA Approves PRE-PEN Penicillin Allergy Test 2Health News:Study Urges Treatment for Even Mild Gestational Diabetes 2Health News:Study Urges Treatment for Even Mild Gestational Diabetes 3Health News:Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery 2Health News:Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery 3Health News:Delayed First Visit to Dentist Can Affect Children's Lifelong Oral Health 2
... (TSH) is a 32 kDa glycoprotein secreted ... pituitary gland [1]. The structure of human ... pituitary and placental gonadotropins, consisting of an ... these hormones and a unique beta-subunit, which ...
... Thyroxine (T4) is the primary active hormone ... thyroid gland [1]. T4 is synthesized via ... trapping by the follicular cells, (ii) iodination ... leading to formation of 3-monoiodotyrosine and 3,5-diiodotyrosine ...
... is produced primarily by 5-monodeioination of thyroxine ... gland, T3 production occurs at a rate ... T4. Release of T3 from the thyroid ... as compared to 80-100 micrograms/day for T4. ...
... Insulin-like growth factor binding protein-3 (IGFBP-3) is the ... postnatal serum, as a component of the ~150 ... a molecule of IGF-I or IGF-II and ALS, ... actions of the IGFs. The molar concentration of ...
Medicine Products: